In hESCs, VitC induces the expression of CD30, which is a biomarker for malignant cells in Hodgkin's disease and embryonal carcinoma cells, through a dramatic loss of DNA methylation of a CpG island in the CD30 promoter [157]. Here, TNFRSF8 is linked to Hodgkins lymphoma.